Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (RBR-586t2rv) titled 'Study to observe the efficacy and safety of plasmapheresis treatment in patients with Focal and Segmental Glomerulosclerosis (FSGS) after kidney transplantation' on Sept. 30.
Study Type: Observational
Primary Sponsor: Hospital do Rim - Escola Paulista de Medicina - Universidade Federal de São Paulo
Condition:
Nephrotic syndrome : focal and segmental glomerular lesions
N00-N08
Intervention:
This is an observational, open-label, prospective, single-arm clinical trial. The total sample size is expected to be 14 participants, who will be followed up for 2 years after the last plasmapheresis session. All patient...